Thomas Jefferson University

Jefferson Digital Commons
Abington Jefferson Health Papers

Abington Jefferson Health

12-15-2019

Role of echocardiography in diagnostic evaluation of patients
admitted to observation unit.
Muhammad Arslan Cheema
Abington Jefferson Health

Hafez Mohammad Ammar Abdullah
University of South Dakota Sioux Falls

Waqas Ullah
Abington Jefferson Health

Yasar Sattar
Icahn School of Medicine at Mount Sinai-Elmhurst Hospital

Shujaul
Haq
Follow this
and additional works at: https://jdc.jefferson.edu/abingtonfp

Abington Jefferson Health
Part of the Cardiology Commons, and the Internal Medicine Commons

Let us know how access to this document benefits you
See next page for additional authors

Recommended Citation
Cheema, Muhammad Arslan; Abdullah, Hafez Mohammad Ammar; Ullah, Waqas; Sattar, Yasar;
Haq, Shujaul; Cheema, Khadija; Ahmad, Asrar; Ali, Zain; and Balaratna, Asoka, "Role of
echocardiography in diagnostic evaluation of patients admitted to observation unit." (2019).
Abington Jefferson Health Papers. Paper 15.
https://jdc.jefferson.edu/abingtonfp/15
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Abington Jefferson Health Papers by an authorized administrator of the Jefferson Digital
Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

Authors
Muhammad Arslan Cheema, Hafez Mohammad Ammar Abdullah, Waqas Ullah, Yasar Sattar, Shujaul Haq,
Khadija Cheema, Asrar Ahmad, Zain Ali, and Asoka Balaratna

This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/abingtonfp/15

Am J Cardiovasc Dis 2019;9(6):127-133
www.AJCD.us /ISSN:2160-200X/AJCD0102869

Original Article
Role of echocardiography in diagnostic evaluation
of patients admitted to observation unit
Muhammad Arslan Cheema1, Hafez Mohammad Ammar Abdullah3, Waqas Ullah1, Yasar Sattar4,
Shujaul Haq1, Khadija Cheema1, Asrar Ahmad1, Zain Ali1, Asoka Balaratna2
Internal Medicine, 2Cardiology, Abington-Jefferson Health, 1200 Old York Road, Abington, PA 19001, USA;
Internal Medicine, University of South Dakota, Sioux Falls, SD 57107, USA; 4Internal Medicine, Icahn School of
Medicine at Mount Sinai-Elmhurst Hospital, 79-01 Broadway Elmhurst, Queen, NY 11373, USA
1
3

Received September 26, 2019; Accepted November 25, 2019; Epub December 15, 2019; Published December
30, 2019
Abstract: Background: Syncope is a transient loss of consciousness due to transient decrease in cerebral perfusion.
Syncope accounts for a 3-6% of all emergency department visits. Etiology of syncope can be neural, cardiogenic, or
vascular. Previous studies have evaluated the types and management of syncope. Echocardiography is a commonly
used test in the evaluation of causes of syncope. Whether the benefit compared to financial burden of this diagnostic study is in all subsets of syncope cases remains unclear. Aim: To evaluate the impact of echocardiography in
the diagnostic evaluation of syncope and to evaluate the subset of patients that would benefit more from this diagnostic imaging. Methods: We performed a retrospective chart review of patients > 18 years of age with a primary
diagnosis of syncope in a period of January 1st 2015-January 31st 2017. Our inclusion criteria included patients >
18 years of age who were admitted to the observation floor with the primary complaint as syncope, had a normal
or abnormal physical examination for syncope, had a normal or abnormal electrocardiogram during admission, had
an echocardiography performed at admission. Our exclusion criteria included patients with seizures, hypoglycemia,
myocardial infarction, patients who didn’t get echocardiography, and patients who had a positive marker of cardiac
injury. Results: A total of 369 patients were initially identified with a primary diagnosis of syncope, however only
120 of these patients fulfilled our inclusion and exclusion criteria. A total of n=25 of included patients had either
an abnormal physical exam or abnormal echocardiography. Among this “high risk” group, 24% (n=6) of the patients
had an abnormal finding on their transthoracic echocardiography. On the other hand, in the “low risk” group with
a normal physical examination and electrocardiogram (EKG), 14 had a trans-thoracic echocardiography (TTE) positive for cause of syncope, that led to a change in medication, workup, or intervention in 6.7% (n=8) of the patients.
Conclusion: The analysis of our study suggested that the diagnostic yield of transthoracic echocardiography in syncope is very limited in the absence of an abnormal physical exam or electrocardiogram, and it increase the health
care cost burden with no additional benefits.
Keywords: Syncope, echocardiography, diagnostic evaluation, observation unit, treatment, outcome

Introduction
Syncope is a form of temporary loss of consciousness with no focal neurologic deficits. It
is usually secondary to a transient decrease
in the blood supply of the brain resulting in loss
of the ability to maintain posture. Syncope is
oftentimes self-resolving and doesn’t require
any intervention [1]. Syncope accounts for up to
3-6% of ED visits. Out of all syncope presentations to the emergency department, 40% of
these patients get admitted. In admitted patients, a detailed workup is usually a practice of

most of hospitals [2-4]. Furthermore, the recurrence rate of syncope admission cases accounts for up to 35% [4]. In addition, the lifetime
probability of getting syncope is 42% in a lifespan of 70 years that results in an annual incidence rate of 6% [5]. The incidence of syncope
increases exponentially with an increase in age.
Syncope was reported to occur in 15% of the
patients < 18 years of age, and around 23% in
age > 18 years [6, 7]. A reported incidence of
syncope in patients age > 60-69 is 5.7 episodes/1000 people per year and for patients >
70 years is 11.1/10000 people per year [7-9].

Echocardiography on observational unit
In patients > 80 years of age, the annual incidence of syncope reaches up-to 19.5 episodes/1000 people [9].
Syncope is broadly divided into neurogenic,
vascular, and cardiogenic. A combination of a
physical examination, orthostatic vitals, and an
electrocardiogram play a key role in diagnosis
of syncope and its subtypes. A complete history/physical examination holds a great significance in categorizing the type of syncope, and
should include the presence of precipitating
factors, presence of prodrome, association
with a change in posture, trauma, associated
symptoms including palpitation, dyspnea, chest
pain, cyanosis, nausea, and vomiting [4]. Physical examinations should include orthostatic
vitals over the 3-5 minute gap between sitting
and standing, along with a cardiovascular and
detailed neurological examination [4]. Physical
examinations should also be focused to rule
out secondary causes of loss of consciousness
including seizures, metabolic abnormalities, stroke, and trauma. The electrocardiogram holds
a great significance in ruling out cardiovascular
causes of syncope [3, 4]. The role of echocardiography in diagnostic evaluation of all cases
of syncope remains unclear, specifically in routine evaluation. Only studies justified its routine
evaluation in cases of syncope by history, physical examination, and electrocardiogram.
Our analysis is focused to see the results of
echocardiography in all cases of syncope, and
correlate whether all cases should get a baseline echocardiography on admission. Our study
also evaluated the frequency of ordering echocardiography in patients with syncope and normal physical exams and electrocardiograms in
the observation unit.
Materials and methods
Ethical considerations
This study was designed with the combined
knowledge and expertise of faculty of AbingtonJefferson Health. This study strictly follows the
Helsinki Ethical guidelines for animals and humans. It also maintains the confidentiality of
the participants.
Patient populations and definitions
We performed a retrospective observational
cohort study to determine the frequency of
ordering echocardiography in patients with syn128

cope on the observation floor and who have a
normal physical exam and electrocardiogram,
and the frequency of positive findings in this
population group. We included all the patients
who were over 18 years of age that were admitted to our observation floor with the primary
diagnosis of syncope from January 1st, 2015 to
January 31st, 2017. Inclusion criteria also constitutes of patients who got electrocardiogram
and echocardiography. Abnormal EKG findings
include arrhythmia, Q waves, ischemic changes, 2nd/3rd degree AV block, paced rhythm, QTc
> 500 ms, left bundle branch block, bi-fascicular block, Abnormal Axis, and Brugada pattern.
Abnormal echocardiography includes right/left
ventricular hypertrophy, right/left ventricular
dysplasia, valvular dysfunction including stenosis or regurgitation, and low left/right ventricular ejection fraction. Included patients also constitutes of normal or abnormal physical exam. A
physical exam that constitutes abnormal criteria includes jugular venous distention, systolic/
diastolic murmurs, S3, S4, and loud S1. Exclusion criteria included patients whose symptoms could be explained by other medical conditions like seizures, hypoglycemia, and MI,
patient who were transferred to acute care,
patients who left against medical advice,
patients who did not get an echocardiogram,
and patients who had positive cardiac biomarkers. Our study population after applying the
inclusion and exclusion criteria was 120
patients. The demographic and clinical characteristics of these patients were taken into
account.
Study population
Among the patient population in hospital location, age, and gender variables were studied.
Among this population, the following comorbidities were studied: hypertension, diabetes mellitus, prior myocardial infarction, prior percutaneous intervention, chronic kidney disease,
prior cardiovascular accident, peripheral vascular disease, anemia, and prior syncope.
Statistical analyses
Descriptive analysis was utilized to describe
the population with syncope and echocardiography. A mean + SD was reported for continuous variables. A percentage and absolute numbers were used for categorical variables. In
order to test for difference in the proportion of
the variables, Fischers exact test was used.
Am J Cardiovasc Dis 2019;9(6):127-133
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Table 1. This table depicts the demographic variables
of a study sample
Patient demographics
Total patient population
Age > 65 years
Age < 65 years
Males
Females

Percentage (%)
120 (100%)
54.2%
45.8%
45.8%
54.2%

Table 2. This table depicts the associated comorbidities in our patients
Number of Percentage
patients
of the
(total n=120) population
Hypertension
61
50.8%
Diabetes Mellitus
39
32.5%
Chronic Kidney Disease
23
19.2%
Prior Myocardial infarction
22
18.3%
Prior syncope
20
16.7%
Prior percutaneous intervention
20
16.7%
Prior cerebrovascular accident
4
3.3%
Peripheral vascular disease
0
0%
Anemia
0
0%
Risk factors

Table 3. This table depicts the physical exam
findings and abnormal vitals in our patient
population
Percentage of the population
(total n=120)
Normal
Abnormal
Physical Exam
84.2% (n=101) 15.8% (n=19)
Orthostatic vitals 98.3% (n=118)
1.7% (n=2)
Parameters

Table 4. This table depicts the rhythm abnormalities in our patient population
Number of Percentage
patients
of the
(total n=120) population
Normal Sinus Rhythm
99
82.5%
Atrial fibrillation
8
6.7%
Atrial flutter
0
0%
LBBB
2
1.7%
RBBB
0
0%
EKG findings

Results
The analysis of our study involved patient population with an age greater or less than 65 years,
and admitted to the observation unit for syn129

cope evaluation. A total of 120 patients
meet our inclusion criteria for syncope
evaluation on observation floor. Among
the sample of 120 patients, 54.2% were
above 65 years of age, 45.8% were under
65 years of age. The gender difference of
included sample showed that 45.8% were
males, and 54.2% were females. A demographic variable of patient population is
shown in Table 1.
The included study population also had
secondary comorbid. A subgroup analysis
of co-morbidities showed hypertension as
a most prevalent among study sample with
up-to 50.8% prevalence. The prevalence
of other comorbidities includes diabetes
(32.5%), chronic kidney disease (19.2%),
prior myocardial infarction (18.3%), prior
percutaneous intervention (16.7%), prior
syncope (16.7%), prior cerebrovascular
event (3.3%). Furthermore, our study sample didn’t have any patients with anemia,
or peripheral vascular disease. A co-morbidities analysis is shown in Table 2.
To subcategories the patients that need
further testing, we subcategories the patients with abnormal physical exam, and abnormal orthostatic vitals. Our sample mostly had a
normal physical exam in 84.2% of the patients
and only 15.8% of patients had an abnormal
exam including heart murmurs, with no carotid
bruit. Further review, also showed that 98.3%
of patients had normal orthostatic vitals. Only 2
patients in our sample had abnormal orthostatic vitals. The analysis of physical exam, and
orthostatic vitals are shown in Table 3.
Analysis of electrocardiogram review in out
patient population showed that 82.5% (n=99)
of the patients had a normal baseline sinus
rhythm with no arrythmias. Arrythmias prevalence review in our sample includes atrial fibrillation (6.7%, n=8), left bundle branch block
(1.7%, n=2), with no right bundle branch block,
or any other arrythmias. An analysis of EKG
findings is shown in Table 4.
Analysis of echocardiographic review of our
patient sample showed aortic stenosis as a
most common echocardiographic finding in
our sample with a prevalence of 18.3%, n=22.
Other percentage of echocardiographic findings include mitral regurgitation (5.8%, n=7),
left ventricular systolic dysfunction (5%, n=6),
Am J Cardiovasc Dis 2019;9(6):127-133
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Table 5. This table depicts the echo findings in our patient population
Echocardiographic findings

Number of patients
(total n=120)
22
7
6
1
0

Aortic Stenosis
Mitral Regurgitation
Left ventricular systolic dysfunction (LVEF < 50%)
Aortic Regurgitation
Mitral Stenosis

Percentage of
the population
18.3%
5.8%
5%
0.8%
0%

Table 6. Patient outcomes with a positive echocardiographic finding
Treatment/Procedure performed
Cath performed
Medication review, management workup, or further workup

Frequency
98.4%
93.44%

Out of total sample
1.6%
6.66%

Table 7. This table depicts the prevalence of positive TTE findings in both the normal and abnormal
physical exam findings groups
Physical exam normal/abnormal
Normal
Abnormal

echocardiography
positive
7/99 (7%)
3/21 (15%)

echocardiography
negative
93/99 (93%)
17/21 (85%)

Table 8. This table depicts the subgroup analysis comparison in
patients with a positive TTE
Difference between positive TTE findings in various groups
Murmur Positive vs no Murmur (Physical exam findings??)
Abnormal EKG vs Normal EKG
Orthostatic Vitals vs no Orthostatic vitals
Prior PCI vs no Prior PCI

aortic regurgitation (0.8%, n=1), and no mitral
stenosis, or other valvular or cardiac pathologies. The echocardiographic findings analysis is
shown in Table 5.
For management of our patient sample, 2
patients (1.6%) with new LBBB got cardiac
catheterization performed for evaluation of
ischemia. Other patients of syncope on observation floor were managed symptomatically by
medication review, controlling inciting agent, or
further workup in only 6.66% (n=8). The patient
outcome of management/workup of positive
echocardiographic and EKG findings are shown
in Table 6.
In our study sample, head to head review of
electrocardiogram and echocardiographic findings of a study sample depicted 15% (n=3) of
the patients had a positive EKG and echocardiographic findings for syncope cause with a
130

Significance
level
P=0.01
P=0.046
P=1.000
P=0.059

Total patients
n=120
n=99 (84.2%)
n=21 (15.8%)

statistically significant results
(P=0.001). Furthermore, 7%
(n=7) of patients had an abnormal echocardiographic finding
with a normal EKG. Analysis of
echocardiographic and physical examination is shown in
Table 7.

A subgroup difference was also
evaluated in positive TTE sample. The patients with a positive TTE findings
with a murmur vs no murmur (P=0.01), abnormal EKG vs normal EKG (P=0.046), and prior
PCI vs no PCI (P=0.05). The results of positive
TTE findings, and subgroup of orthostatic vitals
abnormal vs normal orthostatic vitals were not
statistically significant (P=1.00) likely 2/2 to
low population sample. The analysis of subgroup difference of findings is shown in Table 8.
Discussions
Syncope is a condition where the blood supply
to the brain is reduced for various reasons, and
results in an inability to maintain postural tone
for a while. It has many causes, though they
can be broadly classified into 4 main categories. These are reflex syncope or neural syncope, orthostatic syncope, cardiac arrhythmia,
and cardiopulmonary disease leading to syncope. Some other conditions that can present
Am J Cardiovasc Dis 2019;9(6):127-133
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similarly but need to be differentiated from syncope include seizure disorders, accidental falls,
sleep disturbances, and conversion disorder.
Most of the causes of syncope are relatively
benign, besides the risks inherent to falls.
Cardiac syncope which includes syncope from
vascular disease, cardiomyopathy, arrhythmias, and valvular dysfunction, may be associated with increased mortality and need more
attention. The other causes of syncope do not
increase mortality on their own, but can result
in significant morbidity and disability due to
accidents and falls that may occur as a result
[10]. Besides this, there is also the social
impact including the worsening of the quality of
life, and the economic impact due to hospitalizations. It is estimated that this cost may be up
to 2.4 billion dollars annually [11].
All cases of syncope need to be further evaluated, to rule out any underlying sinister pathology and to help prevent recurrence. This evaluation usually starts with a detailed history focused but not limited to asking about the symptoms onset, any inciting factor(s), any symptoms just prior to the episodes, and also the
past medical history. This is usually followed by
checking orthostatic vitals and a detailed physical exam also focused on the cardiovascular
and neurologic systems, and to identify any hidden trauma. Many of the cases of syncope like
vasovagal and orthostatic hypotension can
easily be identified based on history and a
physical exam. Many other cases however require further evaluation and workup. This usually entails some form of cardiac workup, and
usually starts with an electrocardiogram. Some
of the arrhythmias can be detected by this,
however, paroxysmal arrhythmias may not be
picked up by a 12-lead EKG. Such patient may
require further evaluation with a holter monitor
or a loop recorder if the index of suspicion is
high. An electrocardiogram on the other hand
will not help much with the diagnosis of syncope secondary to structural heart disease or cardiopulmonary disease. These patients would
need to undergo an evaluation by a transthoracic echocardiography (TTE).
Syncope patients who are suspected to have a
cardiac origin of their syncope usually also
undergo transthoracic echocardiography [12].
It can be helpful in both finding the underlying
cause and also stratifying the severity of any
underlying cardiac lesion, like hypertrophic car131

diomyopathy, aortic stenosis, and left ventricular dysfunction [13-15]. It is one of the most
useful imaging modalities for evaluating the
severity of an underlying cardiac disease, and
also the risk stratification of patients who have
unexplained syncope. It is especially useful in
patients who have an abnormal electrocardiogram or patients with a known positive cardiac
history [16]. The exact role of echocardiography
in the workup of syncope is still not clear, especially in syncope patients who do not have any
known history of cardiac conditions and no indication of cardiac pathology in their history,
physical examination, and initial workup of syncope [17, 18]. On the other hand, in patients
with an abnormal electrocardiogram or cardiac
history, a transthoracic echo is usually recommended as part of the evaluation of syncope
[19, 20]. Due to the significant use of financial
and manpower resources associated with echocardiography, studies have been previously
conducted to elucidate the role of echocardiography in syncope patients. There have been
attempts to better streamline the approach of
doing echocardiography in patients presenting
with syncope [21, 22].
Transthoracic echocardiography is used widely
in clinical practice as a screening tool to rule
out valvular or structural heart disease in
patients who present with syncope. It is especially significant in patients who have underlying cardiomyopathy and present with unexplained syncope and also have abnormal findings on their physical exam or an abnormal
electrocardiogram. Transthoracic echocardiography on the other hand in patients with a normal physical exam and normal electrocardiogram is not a very high yield, and it adds to the
additional cost to the patient. Transthoracic
echocardiography costs around 1000 dollars
on average in the US. Inappropriately performed transthoracic echocardiogram may increase the cost of healthcare.
Though the role of transthoracic echo is well
established in patients who have some underlying cardiac disease, however there have been
questions regarding the utility of echocardiography in other patient groups. Current ACC/AHA
guidelines recommend that all the patients who
have a positive cardiac history, or have findings
in the patient’s history and physical, are recommended to undergo a transthoracic echocardiography [23, 24].
Am J Cardiovasc Dis 2019;9(6):127-133
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There have been studies done previously to
better elucidate the role of transthoracic echocardiography in syncope. Recchia et al described a retrospective review in which they found
that 48% of the patients who had a suspected
cardiac origin of the syncope based on history,
physical exam, or electrocardiogram had an
abnormal transthoracic echo [21]. The abnormal echo was not necessarily the underlying
reason for the syncope.
Sarasin et al in another prospective study of
650 patients, found that 24 out of 88 patients
found to have an abnormal electrocardiogram
were also found to have left ventricular systolic
dysfunction on echocardiography. A clinically
significant arrhythmia was also present in
around half of the patients [12]. Our study also
indicates that echocardiography is more useful
and has a higher yield in high risk patients. As
such, our study is consistent with previous
studies described above.
Limitations
Our retrospective study is small and is not as
significant as a large prospective study would
be. Secondly, the physical exam findings and
echocardiogram reads can be variables between different examiners. Also, the diagnosis of
syncope can be subjective and was based on
patient reported symptoms in our study. One
other limitation was that we did not have any
follow up with our patients after discharge.
Conclusion
In conclusion, TTE has a low diagnostic yield in
patients with normal physical exams/electrocardiograms and a high diagnostic yield in
patients with abnormal physical examinations/
electrocardiograms respectively.
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